{"id":9766,"date":"2024-08-13T10:08:22","date_gmt":"2024-08-13T10:08:22","guid":{"rendered":"https:\/\/sescs.es\/?page_id=9766"},"modified":"2024-08-13T10:08:22","modified_gmt":"2024-08-13T10:08:22","slug":"effectiveness-and-cost-effectiveness-of-ozone-treatment-in-managing-patients-with-chemotherapy-induced-paresthesias-numbness-and-tingling-triple-blind-randomized-clinical-trial-ozoparqt","status":"publish","type":"page","link":"https:\/\/sescs.es\/en\/effectiveness-and-cost-effectiveness-of-ozone-treatment-in-managing-patients-with-chemotherapy-induced-paresthesias-numbness-and-tingling-triple-blind-randomized-clinical-trial-ozoparqt\/","title":{"rendered":"Effectiveness and cost-effectiveness of ozone treatment in managing patients with chemotherapy-induced paresthesias (numbness and tingling): triple-blind randomized clinical trial (OzoParQT)"},"content":{"rendered":"

Full Title<\/strong>: Effectiveness and cost-effectiveness of ozone treatment in managing patients with chemotherapy-induced paresthesias (numbness and tingling): triple-blind randomized clinical trial (OzoParQT)<\/p>\n

Funded by<\/strong>: Instituto de Salud Carlos III (FIS PI23\/01324)<\/p>\n

Grant awarded<\/strong>: \u20ac90,000.00<\/p>\n

Duration<\/strong>: 3 years (2024-2026)<\/p>\n

Principal Investigator<\/strong>: Bernardino Clavo Varas, Francisco Javier Rodr\u00edguez Esparragon (Co-PI)<\/p>\n

Associated Researchers<\/strong>: Miguel \u00c1ngel Garc\u00eda Bello (SESCS)<\/p>\n

Objectives and Methodology of the Project<\/strong>:<\/p>\n

Chemotherapy-induced peripheral neuropathy (CIPN) can lead to a reduction and\/or interruption of chemotherapy treatment (tt\u00b0), limiting its effectiveness, and decreasing the patients’ quality of life. Therapeutic options for CIPN are very limited in number and efficacy. Our previous work suggests the potential clinical utility of adjunctive ozone therapy in patients with CIPN.<\/p>\n

MAIN OBJECTIVES<\/strong>:<\/p>\n

    \n
  1. Evaluate the clinical effect and impact on health-related quality of life (HRQoL) of adding ozone to the usual treatment for patients with paresthesias (tingling and\/or numbness) due to CIPN.<\/li>\n
  2. Estimate the additional costs and assess the cost-effectiveness ratio.<\/li>\n<\/ol>\n

    SECONDARY OBJECTIVES<\/strong>: Evaluate the effect on the progression of: 3) Anxiety\/depression levels, 4) Oxidative stress and inflammation parameters.<\/p>\n

    METHODOLOGY<\/strong>: Phase II-III clinical trial, randomized, triple-blind; 42 patients with any tumor, experiencing paresthesias (tingling, numbness) due to CIPN of grade > 2 for > 3 months. All patients will receive standard treatment plus 40 sessions of rectal ozone insufflation over 16 weeks: i) Ozone Group, increasing O3\/O2 concentration from 10 to 30 \u00b5g\/ml; ii) Control-Placebo Group, O3\/O2 concentration = 0 \u00b5g\/ml. Primary Variables<\/strong>: Progression of:<\/p>\n

      \n
    1. Paresthesias (tingling and\/or numbness);<\/li>\n
    2. HRQoL questionnaires (EQ-5D-5L, QLQ-C30, and CIPN20);<\/li>\n
    3. Direct costs. Assessments will be made at: 0 (baseline), 16 (end of ozone insufflation), and 28 weeks (endpoint and end of follow-up).<\/li>\n<\/ol>\n

      Contact Person<\/strong>: Bernardino Clavo Varas<\/p>\n","protected":false},"excerpt":{"rendered":"

      Full Title: Effectiveness and cost-effectiveness of ozone treatment in managing patients with chemotherapy-induced paresthesias (numbness and tingling): triple-blind randomized clinical … <\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[],"tags":[],"class_list":["post-9766","page","type-page","status-publish","hentry"],"yoast_head":"\nEffectiveness and cost-effectiveness of ozone treatment in managing patients with chemotherapy-induced paresthesias (numbness and tingling): triple-blind randomized clinical trial (OzoParQT) | SESCS<\/title>\n<meta name=\"description\" content=\"El Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS) es una unidad dependiente de la Dir. del Servicio Canario de la Salud en la Cons. de Sanidad del Gobierno de Canarias, constituido por investigadores economistas, epidemi\u00f3logos, psic\u00f3logos, soci\u00f3logos, antrop\u00f3logos, bi\u00f3logos, estad\u00edsticos y evaluadores de servicios sanitarios.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sescs.es\/en\/effectiveness-and-cost-effectiveness-of-ozone-treatment-in-managing-patients-with-chemotherapy-induced-paresthesias-numbness-and-tingling-triple-blind-randomized-clinical-trial-ozoparqt\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Effectiveness and cost-effectiveness of ozone treatment in managing patients with chemotherapy-induced paresthesias (numbness and tingling): triple-blind randomized clinical trial (OzoParQT) | SESCS\" \/>\n<meta property=\"og:description\" content=\"El Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS) es una unidad dependiente de la Dir. del Servicio Canario de la Salud en la Cons. de Sanidad del Gobierno de Canarias, constituido por investigadores economistas, epidemi\u00f3logos, psic\u00f3logos, soci\u00f3logos, antrop\u00f3logos, bi\u00f3logos, estad\u00edsticos y evaluadores de servicios sanitarios.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sescs.es\/en\/effectiveness-and-cost-effectiveness-of-ozone-treatment-in-managing-patients-with-chemotherapy-induced-paresthesias-numbness-and-tingling-triple-blind-randomized-clinical-trial-ozoparqt\/\" \/>\n<meta property=\"og:site_name\" content=\"SESCS\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SESCS2018\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"956\" \/>\n\t<meta property=\"og:image:height\" content=\"507\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@_SESCS_\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sescs.es\/en\/effectiveness-and-cost-effectiveness-of-ozone-treatment-in-managing-patients-with-chemotherapy-induced-paresthesias-numbness-and-tingling-triple-blind-randomized-clinical-trial-ozoparqt\/\",\"url\":\"https:\/\/sescs.es\/en\/effectiveness-and-cost-effectiveness-of-ozone-treatment-in-managing-patients-with-chemotherapy-induced-paresthesias-numbness-and-tingling-triple-blind-randomized-clinical-trial-ozoparqt\/\",\"name\":\"Effectiveness and cost-effectiveness of ozone treatment in managing patients with chemotherapy-induced paresthesias (numbness and tingling): triple-blind randomized clinical trial (OzoParQT) | SESCS\",\"isPartOf\":{\"@id\":\"https:\/\/sescs.es\/#website\"},\"datePublished\":\"2024-08-13T10:08:22+00:00\",\"description\":\"El Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS) es una unidad dependiente de la Dir. del Servicio Canario de la Salud en la Cons. de Sanidad del Gobierno de Canarias, constituido por investigadores economistas, epidemi\u00f3logos, psic\u00f3logos, soci\u00f3logos, antrop\u00f3logos, bi\u00f3logos, estad\u00edsticos y evaluadores de servicios sanitarios.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sescs.es\/en\/effectiveness-and-cost-effectiveness-of-ozone-treatment-in-managing-patients-with-chemotherapy-induced-paresthesias-numbness-and-tingling-triple-blind-randomized-clinical-trial-ozoparqt\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sescs.es\/#website\",\"url\":\"https:\/\/sescs.es\/\",\"name\":\"SESCS\",\"description\":\"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud - Reduciendo la incertidumbre en las decisiones\",\"publisher\":{\"@id\":\"https:\/\/sescs.es\/#organization\"},\"alternateName\":\"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sescs.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/sescs.es\/#organization\",\"name\":\"SESCS\",\"alternateName\":\"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud\",\"url\":\"https:\/\/sescs.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sescs.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png\",\"contentUrl\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png\",\"width\":956,\"height\":507,\"caption\":\"SESCS\"},\"image\":{\"@id\":\"https:\/\/sescs.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SESCS2018\",\"https:\/\/x.com\/_SESCS_\",\"https:\/\/www.linkedin.com\/company\/sescs-canarias\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Effectiveness and cost-effectiveness of ozone treatment in managing patients with chemotherapy-induced paresthesias (numbness and tingling): triple-blind randomized clinical trial (OzoParQT) | SESCS","description":"El Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS) es una unidad dependiente de la Dir. del Servicio Canario de la Salud en la Cons. de Sanidad del Gobierno de Canarias, constituido por investigadores economistas, epidemi\u00f3logos, psic\u00f3logos, soci\u00f3logos, antrop\u00f3logos, bi\u00f3logos, estad\u00edsticos y evaluadores de servicios sanitarios.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sescs.es\/en\/effectiveness-and-cost-effectiveness-of-ozone-treatment-in-managing-patients-with-chemotherapy-induced-paresthesias-numbness-and-tingling-triple-blind-randomized-clinical-trial-ozoparqt\/","og_locale":"en_US","og_type":"article","og_title":"Effectiveness and cost-effectiveness of ozone treatment in managing patients with chemotherapy-induced paresthesias (numbness and tingling): triple-blind randomized clinical trial (OzoParQT) | SESCS","og_description":"El Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS) es una unidad dependiente de la Dir. del Servicio Canario de la Salud en la Cons. de Sanidad del Gobierno de Canarias, constituido por investigadores economistas, epidemi\u00f3logos, psic\u00f3logos, soci\u00f3logos, antrop\u00f3logos, bi\u00f3logos, estad\u00edsticos y evaluadores de servicios sanitarios.","og_url":"https:\/\/sescs.es\/en\/effectiveness-and-cost-effectiveness-of-ozone-treatment-in-managing-patients-with-chemotherapy-induced-paresthesias-numbness-and-tingling-triple-blind-randomized-clinical-trial-ozoparqt\/","og_site_name":"SESCS","article_publisher":"https:\/\/www.facebook.com\/SESCS2018","og_image":[{"width":956,"height":507,"url":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@_SESCS_","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/sescs.es\/en\/effectiveness-and-cost-effectiveness-of-ozone-treatment-in-managing-patients-with-chemotherapy-induced-paresthesias-numbness-and-tingling-triple-blind-randomized-clinical-trial-ozoparqt\/","url":"https:\/\/sescs.es\/en\/effectiveness-and-cost-effectiveness-of-ozone-treatment-in-managing-patients-with-chemotherapy-induced-paresthesias-numbness-and-tingling-triple-blind-randomized-clinical-trial-ozoparqt\/","name":"Effectiveness and cost-effectiveness of ozone treatment in managing patients with chemotherapy-induced paresthesias (numbness and tingling): triple-blind randomized clinical trial (OzoParQT) | SESCS","isPartOf":{"@id":"https:\/\/sescs.es\/#website"},"datePublished":"2024-08-13T10:08:22+00:00","description":"El Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS) es una unidad dependiente de la Dir. del Servicio Canario de la Salud en la Cons. de Sanidad del Gobierno de Canarias, constituido por investigadores economistas, epidemi\u00f3logos, psic\u00f3logos, soci\u00f3logos, antrop\u00f3logos, bi\u00f3logos, estad\u00edsticos y evaluadores de servicios sanitarios.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sescs.es\/en\/effectiveness-and-cost-effectiveness-of-ozone-treatment-in-managing-patients-with-chemotherapy-induced-paresthesias-numbness-and-tingling-triple-blind-randomized-clinical-trial-ozoparqt\/"]}]},{"@type":"WebSite","@id":"https:\/\/sescs.es\/#website","url":"https:\/\/sescs.es\/","name":"SESCS","description":"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud - Reduciendo la incertidumbre en las decisiones","publisher":{"@id":"https:\/\/sescs.es\/#organization"},"alternateName":"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sescs.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/sescs.es\/#organization","name":"SESCS","alternateName":"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud","url":"https:\/\/sescs.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sescs.es\/#\/schema\/logo\/image\/","url":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png","contentUrl":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png","width":956,"height":507,"caption":"SESCS"},"image":{"@id":"https:\/\/sescs.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SESCS2018","https:\/\/x.com\/_SESCS_","https:\/\/www.linkedin.com\/company\/sescs-canarias\/"]}]}},"_links":{"self":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/pages\/9766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/comments?post=9766"}],"version-history":[{"count":1,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/pages\/9766\/revisions"}],"predecessor-version":[{"id":9767,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/pages\/9766\/revisions\/9767"}],"wp:attachment":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/media?parent=9766"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/categories?post=9766"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/tags?post=9766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}